Similar Articles
Effect of lntravenous Methylprednisolone (IVMP) on Clinical and Neurophysiological Parameters in Multiple Sclerosis.
Yaşar KÜTÜKÇÜ, Zeki GÖKÇİL, Zeki ODABAŞI, Okay VURAL, Muzaffer YARDIM
Issue: 1996, Volume 2 - Issue 1-2
0
156
THE ROLE OF CYTOKINES IN MULTIPLE SCLEROSIS
Ayşe ALTINTAŞ, Orhun KANTARCI, Aksel SİVA
Issue: 1995, Volume 1 - Issue 4
0
159
Multiple Sclerosis Cases with Atypical Signs
Türe TUNÇBAY, Dilek EVYAPAN, Neşe ÇELEBİSOY
Issue: 1995, Volume 1 - Issue 2
0
168
Evaluation of Depression and Anxiety of Patients with Multiple Sclerosis During the COVID-19 Pandemic: A Comparison with the General Population
Gizem Yağmur Yalçın, Cansu Polat Dunya, Zeliha Tülek, Murat Kürtüncü, Mefkure Eraksoy
DOI: 10.4274/tnd.2021.63444
Issue: 2021, Volume 27 - Supplement 1
0
287
Magnetic Resonance Imaging in the Diagnosis of Multiple Sclerosis
Rana KARABUDAK
Issue: 2009, Volume 15 - Supplement 3
0
283
Multiple Sclerosis Patients with Treatment Failure: Agressive Disease, Switching Treatment, Combination Therapies
Muhteşem GEDİZOĞLU
Issue: 2009, Volume 15 - Supplement 3
0
215
Clinical and Radiological Features of Multiple Sclerosis: Three Case Reports
Murat TERZİ
Issue: 2009, Volume 15 - Supplement 3
0
286
The influence of self-care agency on quality of life in patients with multiple sclerosis
Ahsen Taştan Gürkan, Afitap Özdelikara
DOI: 10.55697/tnd.2024.9
Issue: 2024, Volume 30 - Issue 3
494
252
Determination of important predictors for the fifth-year Expanded Disability Status Scale scores of patients with multiple sclerosis using machine learning
İlknur Buçan Kırkbir, Burçin Kurt, Cavit Boz, Murat Terzi
DOI: 10.55697/tnd.2024.107
Issue: 2024, Volume 30 - Issue 3
444
225